Table 2.

SLEDAI-2K clinical characteristics of flare in patients with monophasic course.

PatientClinical Characteristics in FlareRemission TypeRemission Duration to Most Recent Visit, yrsRaceAge at Diagnosis, yrsEver CSEver AMEver IS
1Arthritis, fever, headache, pericarditis, pleurisySQCQ25.1White41.5YesNoNo
2Organic brain syndrome, fever, mucosal ulcers, pleurisyMixed22.3White60.6YesNoNo
3Fever, rashSACQ7.1White83.1NoNoNo
4Leukopenia, mucosal ulcers, pericarditis, rash, renalMixed27.7White50.4NoNoNo
5Alopecia, rash, renalSQCQ8.7White52.4YesNoYes
6Alopecia, fever, headache, organic brain syndrome, rash, renalMixed25.1Asian22.1YesNoNo
7Arthritis, rashSQCQ11.0White52.1NoYesNo
8Arthritis, leukopeniaMixed12.1Other31.9NoYesNo
9Alopecia, arthritis, pleurisy, rash, renal, vasculitisSACQ8.0Other16.8YesYesNo
10Arthritis, fever, rash, thrombocytopeniaMixed11.5White12.1NoYesNo
11Leukopenia, renalSQCQ5.8Other36.2YesYesNo
  • SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; CS: corticosteroids; AM: antimalarials; IS: immunosuppressives; SQCQ: serologically and clinically quiescent; SACQ: serologically active clinically quiescent.